The practical nurse (PN) is obtaining information from a female client who is starting a new prescription for conjugated estrogens 0.625 mg PO daily. Prior to the client taking the first dose of the medication, which information should the PN obtain?

Choice A reason: Immune status is critical before administering the influenza vaccine, as immunocompromised individuals may have reduced vaccine efficacy or increased risk of adverse reactions. Conditions like HIV or chemotherapy weaken immune responses, requiring tailored vaccination strategies. Assessing immune status ensures the vaccine is safe and effective, guiding clinical decisions.

Choice B reason: While age influences vaccine type (e.g., high-dose for older adults), it is less critical than immune status for safety. Age is typically already known from records and does not directly affect immediate vaccine administration decisions. This choice is less relevant compared to immune status evaluation.

Choice C reason: Food allergies are generally irrelevant to influenza vaccines, which are not derived from food allergens. However, egg allergies may be considered for certain vaccines due to manufacturing processes, but this is distinct from food allergies broadly. This choice is incorrect as it lacks direct relevance.

Choice D reason: Gender does not impact influenza vaccine administration. Vaccine efficacy and safety are not significantly influenced by gender-specific physiological differences. This choice is incorrect, as it does not provide critical information needed to ensure the vaccine’s safety or effectiveness for the client.

Choice A reason: Donepezil, a cholinesterase inhibitor, increases acetylcholine in the brain, enhancing cognitive function in early Alzheimer’s. It improves memory and daily functioning by supporting neuronal communication, particularly in mild-to-moderate stages, slowing symptom progression temporarily, making this the accurate description of its action.

Choice B reason: Donepezil does not target psychotic features, like hallucinations, which are managed with antipsychotics. It enhances cognitive function by boosting acetylcholine, not addressing behavioral symptoms. Psychotic features require different therapies, making this choice incorrect for donepezil’s primary role.

Choice C reason: Donepezil does not alter Alzheimer’s progressive course, as it cannot stop neuronal degeneration. It provides symptomatic relief by enhancing acetylcholine levels, temporarily improving cognition, but the disease’s underlying pathology continues, making this choice inaccurate for describing the drug’s effect.

Choice D reason: Donepezil does not cause sedation or reduce hostility. It enhances cognitive function, potentially increasing alertness. Sedation is a side effect of other drugs, like antipsychotics, not cholinesterase inhibitors, making this choice incorrect for donepezil’s therapeutic action.